Scandinavian Intensive Care Unit (ICU) Glutamine Study

NCT00922714 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

1000

Enrollment

OTHER

Sponsor class

Stopped Slow recruitment, stopped after 4 years

Conditions

ICU Patients

Interventions

DRUG: Glutamine
DRUG: saline (placebo)

Sponsor

Scandinavian Critical Care Trials Group